DCN and obesity disorder: In the present study, we used the well-established C57BL/6 mouse model for obesity and impaired glucose tolerance and type 2 diabetes30, to test a possible causal impact of decorin on body weight, glucose tolerance and adipose tissue in high-fat challenged Dcn null (dcnKO) C57BL/6J mice.